// App-Quantinova.ai

3782 : Development of a dual inhibitor of pan-RAF and VEGFR2 for the treatment of metastatic colorectal cancer with mutant K-RAS

Researchers

Presenter

  • Sungpyo Hong

Principal Investigators

  • Young-Il Choi

  • Jihye Choi

  • Wonyoung Kim

  • Ho-Seok Kwon

  • Yong Bin Park

  • Min-Hyo Ki

  • Hee Jong Shin

  • Michael Lee

  • Soon Kil Ahn

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Samjin Pharm. Co., L

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Melanoma

  • Solid malignancies

Biomarkers

  • Mitogen-activated protein kinase

  • Epidermal growth factor receptor

  • Kinase Insert Domain Receptor

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved